VA Ann Arbor Healthcare System
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, VA Ann Arbor Healthcare System sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
VA Ann Arbor Healthcare System: 5 sponsored US clinical trials, 1 recruiting.
VA Ann Arbor Healthcare System sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 4 completed. 2 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Liver Metastases, with 1 trials.
Upper-quartile sponsor footprint
VA Ann Arbor Healthcare System sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung Cancer
NCT05430009
Low-Carbohydrate Diabetes Prevention Program Among Veterans With Prediabetes
NCT04881890
Ketamine Infusion for Comorbid PTSD and Chronic Pain
NCT04322968
Modulation of Steroid Immunosuppression by Alveolar Efferocytosis
NCT03034642
PROlonGed ExpoSure Sertraline
NCT01524133
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Therapeutic Areas
Where VA Ann Arbor Healthcare System enrollment is open (later-stage tilt)
1 recruiting of 5 indexed (20% open); 4 completed (80%).
Phase mix: 2 late (III/IV) vs 1 early (I/II) (later-stage heavy).
Top condition: Liver Metastases (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
VA Ann Arbor Healthcare System: open-pipeline peers nationwide
Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
VA Ann Arbor Healthcare System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
- Amazentis · 20% recruiting · 5 trials
Related
What to do with this VA Ann Arbor Healthcare System page
5 registered trials is a research-attention snapshot, not an endorsement of VA Ann Arbor Healthcare System or any single study.
- 1 of VA Ann Arbor Healthcare System's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Liver Metastases is the condition VA Ann Arbor Healthcare System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Liver Metastases trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
VA Ann Arbor Healthcare System pipeline card: 5 registered trials from official public datasets.Report a data error.